Glaxosmithkline Pakistan Limited · PSX:GLAXO
Glaxosmithkline Pakistan — Investor Presentation (2021)
24 slides from Glaxosmithkline Pakistan's investor presentation, 2021
Slide 1: Corporate briefing session - 2021
Corporate briefing session - 2021 GlaxoSmithKline Pakistan Limited Hunza, Pakistan
Slide 2: Agenda
Agenda Economic Overview Company overview PSX Corporate Briefing Our Achievements Financial Outline Questions & Answers 2
Slide 3: Economic Overview
Economic Overview
Slide 4: Economy remains volatile – Direction and policies set for a strong recovery
Economic Overview Economy remains volatile – Direction and policies set for a strong recovery Economic Overview • The economy recovered significantly from the COVID-induced deceleration. The expansion led by private consumption, strong remittance inflows and a large increase in fixed-capital expendi
Slide 5: Company’s Overview
Company’s Overview
Slide 6: Our Local Footprint
Our Local Footprint Registered Office: 35-Dockyard Road, West Wharf, Karachi Sales Offices: Karachi , Lahore, Multan , Islamabad , Peshawar Head Office at Wharf Office Factories in Pakistan F-268 West Wharf Korangi 6
Slide 7: Board of Directors and Key changes
Board of Directors and Key changes Mr. Dmytro Oliinyk Ms. Erum Shakir Rahim Mr. Hasham Baber Ms. Maheen Rahman Mr. Muneer Kamal Mr. Mehmood Mr. Mark Dawson Chairman Chief Executive Officer Chief Financial Officer Independent Director Independent Director Mandviwalla Non-Executive Director Non-Execut
Slide 8: Our Purpose, Goal and Strategy
Our Purpose, Goal and Strategy We are a science-led global healthcare company with a special purpose to improve the quality of human life by helping Who we are people do more, feel better, live longer We aim to bring differentiated, high-quality and needed healthcare products to as many people as po
Slide 9: Our Values & Expectations are at the Heart of Everything We Do
Our Values & Expectations are at the Heart of Everything We Do Patient focus 9
Slide 10: Key Therapy areas and Brands in Pakistan
Key Therapy areas and Brands in Pakistan Antibiotic Dermatology Respiratory Analgesics Vaccines Others (45% of sales) (19% of sales) (5% of sales) (7% of sales) (1% of sales) (23% of sales) 10
Slide 11: GSK Pakistan: A Legacy of Success
GSK Pakistan: A Legacy of Success #1 on MAT in Value #1 on MAT in Volume 2 Brands in industry top 10 in Value 3 manufacturing sites; 377 million units in a year 4 Brands in industry top 10 in Volume Listed entity in Pakistan stock exchange since 1951 with Market Cap of Rs. 42.8b* Source: IQVIA MAT S
Slide 12: WhatsApp 1:Many Channel
WhatsApp 1:Many Channel Three primary uses: Consent Collection . WhatsApp 1: Many Launch Engage HCPs through 24 hours active Chatbot ✓ 1st across GSK world ✓ 1st Pharma Company in the world Broadcast Medical & Marketing campaigns
Slide 13: Our Awards and Recognitions
Our Awards and Recognitions
Slide 14: Top employer 2021
Top employer 2021
Slide 15: Best place to work
Best place to work GSK Pakistan is declared as the Most Preferred Employer in Pharmaceutical Industry - Awards given since 2012, Survey conducted in August - 160 Organizations across Industries
Slide 16: PSC Carbon & Water Trophy 2021
PSC Carbon & Water Trophy 2021 Winner (Carbon): Karachi F268 Projects delivering a very substantial reduction in 2021 and establishing the foundations for fossil fuel elimination & NZC Winner (Water) : Karachi West Wharf Track record of successes, strong project plan, excellent programme, significan
Slide 17: Best corporate report award
Best corporate report award GSK Pakistan secured third position in Pharma Category Extensive Best Corporate Report criteria set out by professional accounting bodies (ICAP & ICMAP) to ascertain BCR award. 3rd GlaxoSmithKline Pakistan Limited
Slide 18: Financial Outline
Financial Outline
Slide 19: Financial Performance
Financial Performance Sales for the year (Rs. in bn) • Accelerating pharma business through increased HCP coverage, introducing multi 33.9 31.9 channel engagement and trade channel 29.9 28.7 investment 25.1 • The Company delivered operating profit Rs. 4.4 bn for nine months. • Healthy dividend payou
Slide 20: Key Financial Highlights
KEY FINANCIAL HIGHLIGHTS September 2021 Net Sales * Gross profit Profit before Earning per Rs. 26.6 Gross margin Rs. 6.98 tax share Billion 26.3% billion Rs.4.4 Billion Rs. 9.11 September 2020 Net Sales Gross profit Profit before Earning per Gross margin Rs. 26.6 Rs. 6.03 tax share 22.7% Billion bil
Slide 21: Key Financial Ratios
KEY FINANCIAL RATIOS Balance Sheet Ratios September 30, September 30, 2021 2020 Return on equity 16% 14% Current Ratio 2.03 1.97 Inventory days 126 114 Receivable days 20 19 Payable days 39 42 21
Slide 22: Outlook and Challenges
Outlook and Challenges At a glance We hope to sustain the growth trajectory by ensuring our growth in line with pharma market growth by investing in core brands effectively. We continued to leverage our accelerated digital transformation to effectively engage with Health Care Professionals (HCPs). A
Slide 23: Questions & Answers
Questions & Answers
Slide 24: Conclusion of session: Thank You
Conclusion of session Thank You
GlaxoSmithKline Pakistan — Investor Presentation (2021) on 6ix